NAMSR News: Marketing of Non-Invasive Device to Help Evaluate Heart Blood Flow Allowed by FDA

The U.S. FDA has allowed marketing of the HeartFlow FFR-CT software, which permits health care professionals to non-invasive evaluate blood flow in the coronary arteries of patients showing signs and symptoms of coronary artery disease.



via Education - Latest News http://ift.tt/1rW9Leh